Hims & Hers Health (HIMS) Short Interest Ratio & Short Volume $27.80 -0.14 (-0.49%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Hims & Hers Health Short Interest DataHims & Hers Health (HIMS) has a short interest of 52.12 million shares, representing 29.37% of the float (the number of shares available for trading by the public). This marks a 21.29% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.2, indicating that it would take 3.2 days of the average trading volume of 9.74 million shares to cover all short positions.Current Short Interest52,120,000 sharesPrevious Short Interest42,970,000 sharesChange Vs. Previous Month+21.29%Dollar Volume Sold Short$1.26 billionShort Interest Ratio3.2 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares218,480,000 sharesFloat Size177,450,000 sharesShort Percent of Float29.37%Today's Trading Volume18,842,443 sharesAverage Trading Volume9,739,798 sharesToday's Volume Vs. Average193% Short Selling Hims & Hers Health? Sign up to receive the latest short interest report for Hims & Hers Health and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHIMS Short Interest Over TimeHIMS Days to Cover Over TimeHIMS Percentage of Float Shorted Over Time Hims & Hers Health Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/202452,120,000 shares $1.26 billion +21.3%29.4%3.2 $24.18 12/15/202442,970,000 shares $1.29 billion +0.8%24.2%2.6 $30.02 11/30/202442,620,000 shares $1.37 billion +7.8%24.0%2.7 $32.22 11/15/202439,520,000 shares $765.11 million +16.8%22.3%2.7 $19.36 10/31/202433,840,000 shares $637.71 million +6.2%19.1%3.1 $18.85 10/15/202431,870,000 shares $726.64 million +28.7%18.3%3.2 $22.80 9/30/202424,760,000 shares $456.20 million -6.7%14.2%2.6 $18.43 9/15/202426,540,000 shares $439.77 million -5.4%16.2%3 $16.57 8/31/202428,040,000 shares $413.03 million +21.7%17.1%3 $14.73 8/15/202423,040,000 shares $362.07 million +19.6%14.0%2.2 $15.72 Get the Latest News and Ratings for HIMS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. 7/31/202419,260,000 shares $409.08 million -2.8%12.7%1.6 $21.24 7/15/202419,810,000 shares $452.46 million +12.8%13.1%1.9 $22.84 6/30/202417,560,000 shares $354.54 million +3.3%11.7%1.7 $20.19 6/15/202417,000,000 shares $403.75 million -19.7%11.3%1.8 $23.75 5/31/202421,160,000 shares $410.93 million -4.4%14.0%2.5 $19.42 5/15/202422,130,000 shares $305.62 million +20.3%14.7%2.7 $13.81 4/30/202418,390,000 shares $230.24 million +5.3%13.2%3 $12.52 4/15/202417,470,000 shares $230.95 million +34.6%12.5%3.5 $13.22 3/31/202412,980,000 shares $200.80 million +1.7%9.4%2.8 $15.47 3/15/202412,760,000 shares $186.81 million +0.9%9.2%2.9 $14.64 2/29/202412,650,000 shares $164.96 million -6.1%9.1%3.1 $13.04 2/15/202413,470,000 shares $135.37 million -6.6%10.0%4.1 $10.05 1/31/202414,420,000 shares $123.72 million -5.2%10.6%4.8 $8.58 1/15/202415,210,000 shares $130.35 million +1.1%11.2%5.3 $8.57 12/31/202315,040,000 shares $133.86 million -4.0%11.1%5.3 $8.90 12/15/202315,670,000 shares $132.33 million -7.9%11.5%6 $8.45 11/30/202317,020,000 shares $151.31 million -1.7%12.5%6.7 $8.89 11/15/202317,310,000 shares $133.63 million +2.1%12.8%7.2 $7.72 10/31/202316,960,000 shares $101.42 million -0.9%12.6%6.9 $5.98 10/15/202317,120,000 shares $107 million -3.0%12.7%6.7 $6.25 9/30/202317,640,000 shares $110.96 million +5.4%13.1%6.5 $6.29 9/15/202316,730,000 shares $105.57 million +0.5%12.4%5.9 $6.31 8/31/202316,650,000 shares $111.72 million -5.8%12.4%5.6 $6.71 8/15/202317,680,000 shares $127.03 million -21.4%13.1%5.4 $7.19 7/31/202322,480,000 shares $201.53 million -8.2%16.9%6.5 $8.97 7/15/202324,490,000 shares $216.98 million +10.9%18.4%7.7 $8.86 6/30/202322,090,000 shares $207.65 million +4.8%16.6%6.5 $9.40 6/15/202321,080,000 shares $185.50 million +3.9%15.8%6.2 $8.80 5/31/202320,280,000 shares $181.30 million -3.2%15.3%5.8 $8.94 5/15/202320,940,000 shares $225.52 million -7.0%17.0%5.4 $10.77Vladimir Lenin was right… (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. 4/30/202322,510,000 shares $260.89 million -2.0%18.4%6.1 $11.59 4/15/202322,960,000 shares $224.09 million +2.5%18.9%6.7 $9.76 3/31/202322,410,000 shares $222.31 million +7.1%18.5%7.6 $9.92 3/15/202320,930,000 shares $188.58 million +9.8%17.3%8 $9.01 2/28/202319,060,000 shares $214.81 million +5.8%15.8%8.2 $11.27 2/15/202318,010,000 shares $180.64 million +4.4%15.9%10.5 $10.03 1/31/202317,260,000 shares $142.91 million +5.2%16.2%9.1 $8.28 1/15/202316,400,000 shares $123.49 million +1.5%15.4%9.5 $7.53 12/30/202216,160,000 shares $103.59 million No Change15.2%9.2 $6.41 12/15/202216,160,000 shares $111.50 million -1.8%15.2%9.2 $6.90 11/30/202216,460,000 shares $101.89 million +3.1%15.5%9.5 $6.19 11/15/202215,970,000 shares $98.85 million +21.2%15.1%9.4 $6.19 10/31/202213,180,000 shares $59.84 million -5.4%12.5%8.1 $4.54 10/15/202213,930,000 shares $66.45 million +6.5%13.2%8.9 $4.77 9/30/202213,080,000 shares $72.99 million -4.1%12.4%8.3 $5.58 9/15/202213,640,000 shares $82.25 million +2.3%12.9%7.1 $6.03 8/31/202213,340,000 shares $84.84 million +0.7%12.7%6.5 $6.36 8/15/202213,250,000 shares $95.67 million +6.6%12.6%6.3 $7.22 7/31/202212,430,000 shares $76.94 million +1.0%12.1%5.3 $6.19 7/15/202212,310,000 shares $67.83 million +4.4%12.0%5.4 $5.51 6/30/202211,790,000 shares $53.41 million +27.1%11.5%5.1 $4.53 6/15/20229,280,000 shares $37.77 million +3.3%9.1%4.1 $4.07 5/31/20228,980,000 shares $36.28 million -7.6%8.8%4.2 $4.04 5/15/20229,720,000 shares $33.53 million +12.0%9.5%4 $3.45 4/30/20228,680,000 shares $36.54 million +7.8%7.9%4 $4.21 4/15/20228,050,000 shares $40.73 million -1.8%7.3%3.5 $5.06 3/31/20228,200,000 shares $43.71 million -8.1%7.5%3.5 $5.33 3/15/20228,920,000 shares $38.71 million -13.8%8.1%3.7 $4.34 2/28/202210,350,000 shares $54.03 million +5.5%9.4%4.3 $5.22 2/15/20229,810,000 shares $47.77 million +20.2%8.9%4 $4.87 1/31/20228,160,000 shares $39.82 million +5.2%8.4%3.1 $4.88 1/15/20227,760,000 shares $41.05 million -11.2%8.0%3 $5.29 12/31/20218,740,000 shares $57.25 million -7.3%9.0%3.5 $6.55 12/15/20219,430,000 shares $59.88 million -2.3%9.7%3.8 $6.35 11/30/20219,650,000 shares $63.21 million +14.7%10.0%4 $6.55 11/15/20218,410,000 shares $68.71 million +23.5%7.9%3.4 $8.17 10/29/20216,810,000 shares $53.12 million +10.0%8.8%2.8 $7.80 10/15/20216,190,000 shares $51.75 million -3.4%8.0%2.4 $8.36 9/30/20216,410,000 shares $48.33 million +13.1%8.3%2.5 $7.54 9/15/20215,670,000 shares $49.10 million +2.0%7.3%2.3 $8.66 8/31/20215,560,000 shares $43.81 million -22.5%7.9%2.3 $7.88 8/13/20217,170,000 shares $60.01 million +16.6%10.2%3.2 $8.37 7/30/20216,150,000 shares $48.65 million -41.8%9.3%3.2 $7.91 7/15/202110,560,000 shares $103.17 million -4.4%15.8%6.6 $9.77 6/30/202111,040,000 shares $120.23 million -11.3%16.5%7.5 $10.89 6/15/202112,450,000 shares $150.27 million -11.3%18.6%8.6 $12.07 5/28/202114,040,000 shares $202.32 million -2.8%21.0%8.5 $14.41 5/14/202114,440,000 shares $117.83 million +18.2%21.7%7.8 $8.16 4/30/202112,220,000 shares $149.94 million +5.8%17.7%6.5 $12.27 4/15/202111,550,000 shares $141.95 million +19.6%17.2%5 $12.29Vladimir Lenin was right… (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. 3/31/20219,660,000 shares $121.91 million +71.9%14.6%4.3 $12.62 3/15/20215,620,000 shares $88.63 million +50.7%8.5%2.5 $15.77 2/26/20213,730,000 shares $56.02 million +43.5%5.7%2 $15.02 2/12/20212,600,000 shares $55.59 million +165.5%4.0%1.6 $21.38 1/29/2021979,200 shares $16.22 million +237.1%N/A0.8 $16.56 1/15/2021290,500 shares $6.83 million No ChangeN/A0.3 $23.50 HIMS Short Interest - Frequently Asked Questions What is Hims & Hers Health's current short interest? Short interest is the volume of Hims & Hers Health shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 52,120,000 shares of HIMS short. 29.37% of Hims & Hers Health's shares are currently sold short. Learn More on Hims & Hers Health's current short interest. What is a good short interest ratio for Hims & Hers Health? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HIMS shares currently have a short interest ratio of 3.0. Learn More on Hims & Hers Health's short interest ratio. Which institutional investors are shorting Hims & Hers Health? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Hims & Hers Health: Jane Street Group LLC, Wolverine Trading LLC, Walleye Trading LLC, Walleye Capital LLC, Crawford Fund Management LLC, PEAK6 Investments LLC, and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Hims & Hers Health? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 29.37% of Hims & Hers Health's floating shares are currently sold short. Is Hims & Hers Health's short interest increasing or decreasing? Hims & Hers Health saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 52,120,000 shares, an increase of 21.3% from the previous total of 42,970,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Hims & Hers Health's float size? Hims & Hers Health currently has issued a total of 218,480,000 shares. Some of Hims & Hers Health's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hims & Hers Health currently has a public float of 177,450,000 shares. How does Hims & Hers Health's short interest compare to its competitors? 29.37% of Hims & Hers Health's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Hims & Hers Health: Fresenius Medical Care AG (0.14%), RadNet, Inc. (5.42%), Option Care Health, Inc. (2.26%), Guardant Health, Inc. (6.30%), Sotera Health (4.58%), Veracyte, Inc. (3.60%), BrightSpring Health Services, Inc. (16.20%), LifeStance Health Group, Inc. (8.88%), Surgery Partners, Inc. (14.89%), Privia Health Group, Inc. (5.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Hims & Hers Health stock? Short selling HIMS is an investing strategy that aims to generate trading profit from Hims & Hers Health as its price is falling. HIMS shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hims & Hers Health? A short squeeze for Hims & Hers Health occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HIMS, which in turn drives the price of the stock up even further. How often is Hims & Hers Health's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HIMS, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies Natera Short Interest Data Fresenius Medical Care Short Interest Data Option Care Health Short Interest Data Guardant Health Short Interest Data RadNet Short Interest Data Sotera Health Short Interest Data BrightSpring Health Services Short Interest Data Veracyte Short Interest Data LifeStance Health Group Short Interest Data Privia Health Group Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:HIMS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.